health

AAN 2025: Tavapadon offers rapid, sustained motor benefits - Parkinson's News Today

Tavapadon eased motor symptoms in a month when given at either a fixed or flexible dose to adults with early-stage disease, data showed.

By:Margarida Maia, PhD
Source:Parkinson's News Today
Published:
AAN 2025: Tavapadon offers rapid, sustained motor benefits - Parkinson's News Today
Tavapadon, an orally available small molecule being developed for Parkinson’s disease, was generally safe and eased motor symptoms within one month of being administered at either a fixed or flexible… [+6280 chars]

Related News